Literature DB >> 18333046

Supra-elevated CA 19-9 in a benign hepatic cyst adenoma.

C R Scoggins1, D Moore, K Washington, J K Wright, R S Chari.   

Abstract

BACKGROUND: Elevated CA 19-9 may be found in both cystadenomas and cystadenocarcinomas of the liver. CASE OUTLINE: A 59-year-old woman presented with right upper quadrant abdominal pain, malaise and weight loss. Physical examination and laboratory evaluation revealed a mass in the right upper quadrant and a CA 19-9 level of 68 661 U/ml. CT scan demonstrated a cystic liver mass. She underwent a right hepatectomy, and her CA 19-9 returned to normal. Pathologic analysis revealed no malignancy. DISCUSSION: In hepatic cystic neoplasms, an elevated CA 19-9 should not be used to establish the diagnosis of malignancy nor should it preclude resection.

Entities:  

Year:  2004        PMID: 18333046      PMCID: PMC2020653          DOI: 10.1080/13651820310015806

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  5 in total

1.  A case of inflammatory pseudotumor of the liver causing elevated serum CA19-9 levels.

Authors:  T Ogawa; H Yokoi; Y Kawarada
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

2.  Serum and cystic fluid CA 19-9 determinations as a diagnostic help in liver cysts of uncertain nature.

Authors:  Y Horsmans; A Laka; J F Gigot; A P Geubel
Journal:  Liver       Date:  1996-08

3.  Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change.

Authors:  D A Wheeler; H A Edmondson
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

4.  Giant biliary cystadenoma: case report and literature review.

Authors:  S S Florman; D P Slakey
Journal:  Am Surg       Date:  2001-08       Impact factor: 0.688

5.  Cystadenomas of the liver: a spectrum of disease.

Authors:  E Dixon; F R Sutherland; P Mitchell; G McKinnon; V Nayak
Journal:  Can J Surg       Date:  2001-10       Impact factor: 2.089

  5 in total
  2 in total

1.  Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT.

Authors:  Ji Yang Kim; Se Hyung Kim; Soo Young Kim
Journal:  Eur Radiol       Date:  2014-08-12       Impact factor: 5.315

Review 2.  Biomarkers in pancreatic adenocarcinoma: current perspectives.

Authors:  Douglas S Swords; Matthew A Firpo; Courtney L Scaife; Sean J Mulvihill
Journal:  Onco Targets Ther       Date:  2016-12-09       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.